Related references
Note: Only part of the references are listed.Slow myosin heavy chain expression in the absence of muscle activity
O. Agbulut et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Role of Adenosine 5′-Monophosphate-Activated Protein Kinase in Interleukin-6 Release from Isolated Mouse Skeletal Muscle
Stephan Glund et al.
ENDOCRINOLOGY (2009)
Thienopyridone Drugs Are Selective Activators of AMP-Activated Protein Kinase β1-Containing Complexes
John W. Scott et al.
CHEMISTRY & BIOLOGY (2008)
Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients
H. Boon et al.
DIABETOLOGIA (2008)
A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism
Daniel Moreno et al.
FEBS LETTERS (2008)
Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity
Alexandra Chadt et al.
NATURE GENETICS (2008)
Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease
D. Grahame Hardie
FEBS LETTERS (2008)
AMP activated protein kinase: a next generation target for total metabolic control
Parimal Misra
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase
Olga Goeransson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family
Matthew J. Sanders et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes
Lijun Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Lack of AMPKα2 enhances pyruvate dehydrogenase activity during exercise
Ditte K. Klein et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
5-aminoimidazole-4-carboxamide 1-β-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men
Daniel J. Cuthbertson et al.
DIABETES (2007)
AS160 phosphorylation is associated with activation of α2β2γ1- but not α2β2γ3-AMPK trimeric complex in skeletal muscle during exercise in humans
Jonas T. Treebak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
AMP-activated protein kinase in metabolic control and insulin signaling
Mhairi C. Towler et al.
CIRCULATION RESEARCH (2007)
Role of AMPK alpha 2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle
Sebastian B. Jorgensen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Predominant α2/β2/γ3 AMPK activation during exercise in human skeletal muscle
J. B. Birk et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Ouabain induces cell proliferation through calcium-dependent phosphorylation of Akt (protein kinase B) in opossum kidney proximal tubule cells
Syed J. Khundmiri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Signaling pathways involving the sodium pump stimulate NO production in endothelial cells
Alexander Eva et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
AS160 regulates insulin- and contraction-stimulated glucose uptake in mouse skeletal muscle
Henning F. Kramer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cardiotonic steroids stimulate glycogen synthesis in human skeletal muscle cells via a Src- and ERK1/2-dependent mechanism
Olga Kotova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits
Jonas T. Treebak et al.
DIABETES (2006)
Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle
Henning F. Kramer et al.
DIABETES (2006)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation
B Guigas et al.
DIABETES (2006)
5′AMP activated protein kinase expression in human skeletal muscle:: effects of strength training and type 2 diabetes
JFP Wojtaszewski et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Long-term AICAR administration and exercise prevents diabetes in ZDF rats
R Pold et al.
DIABETES (2005)
AMP kinase and malonyl-CoA: Targets for therapy of the metabolic syndrome
N Ruderman et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Cloning and characterization of mouse 5′-AMP-activated protein kinase γ3 subunit
HY Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Expression profiling of the γ-subunit isoforms of AMP-activated protein kinase suggests a major role for γ3 in white skeletal muscle
M Mahlapuu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Knockout of the α2 but not α1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside- but not contraction-induced glucose uptake in skeletal muscle
SB Jorgensen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism
J Liu et al.
KIDNEY INTERNATIONAL (2004)
The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism
SA Hawley et al.
DIABETES (2002)
The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways
LGD Fryer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome
ES Buhl et al.
DIABETES (2002)
5-aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice
XM Song et al.
DIABETOLOGIA (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Inhibition of Na,K-ATPase activates P13 kinase and inhibits apoptosis in LLC-PK1 cells
XM Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Mutation of the IIB myosin heavy chain gene results in muscle fiber loss and compensatory hypertrophy
DL Allen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)
Muscle phosphorylase kinase is not a substrate of AMP-activated protein kinase
A Beyer et al.
BIOLOGICAL CHEMISTRY (2000)
Share Paper
